Overview

Insulinotropic Effect of GLP-1 and GIP After Dexamethasone

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
In this study we examine whether inducing insulin resistance by dexamethasone in healthy volunteers will lead to a decreased insulinotropic effect of the hormones GLP-1 and GIP.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Gastric Inhibitory Polypeptide
Glucagon-Like Peptide 1
Criteria
Inclusion Criteria:

- Caucasians above 20 and below 45 years of age

- Normal glucose tolerance as assessed by the WHO criteria

- First degree relative and at least 1 second degree relative with type 2 diabetes

- Normal haemoglobin

- Informed consent

Exclusion Criteria:

- Liver disease (ALAT/ASAT > 2 times normal value)

- Kidney disease (S-creatinin > 130uM and/or albuminuria)

- Heart disease (NYHA II, III or IV)

- Treatment with medicine that cannot be paused

- Pregnancy of breast feeding